Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients Presenting With Locally Advanced Breast Cancer: A Prospective Study

NCT03255577 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT03255577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03255577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients Presenting With Locally Advanced Breast Cancer: A Prospective Study
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 17, 2017
Completion date
August 30, 2027
Enrollment
162 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, locally advanced breast cancer